VACCINE AND TREATMENT EVALUATION UNITS: PHASE I TRIAL TO EVALUATE THERAPEUTICS FOR RESISTANT BACTERIAL INFECTIONS

NIH RePORTER · NIH · N01 · $31,500 · view on reporter.nih.gov ↗

Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

Key facts

NIH application ID: 10578643
Project number: 272201300017I-P00006-27200022-1
Recipient: DUKE UNIVERSITY
Principal Investigator: EMMANUEL B WALTER
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $31,500
Award type: —
Project period: 2017-08-28 → 2022-12-31